Skip to main content

Advertisement

Log in

Abatacept as an option therapy in difficult to treat psoriatic arthritis

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Psoriatic arthritis (PA) is an inflammatory arthritis associated with cutaneous psoriasis. Treatment consists of non-steroidal anti-inflammatory drugs, corticosteroids at low doses and disease-modifying anti-rheumatic drugs. We relate a case of PA that after the fault of the handlings convecionais to sick we opted for an empiric treatment with Abatacept, based on the current knowledge on the physiopathology of PA and its low hepatotoxicity found in an animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fitzgerald O (2008) Psoriatic arthritis. In: Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS (eds) Kelley’s textbook of rheumatology. Available via DIALOG. http://www.mdconsult.com/das/book/body/132831804-2/0/1807/528.html. Accessed 21 Apr 2009

  2. Ritchlin C (2008) Psoriatic arthritis: pathology and pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, White PH (eds) Primer on the rheumatic diseases. Springer Science, New York, pp 178–184

    Chapter  Google Scholar 

  3. Jones G, Crotty M, Brooks P (2008) Intervenciones para el tratamiento de la artritis psoriásica (Cochrane Review). In: La Biblioteca Cochrane Plus, Issue 3. Available via DIALOG. http://www.update-software.com/abstractsES/AB000212-ES.htm. Accessed 21 Apr 2009

  4. Nash P, Clegg DO (2005) Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 64(Suppl II):ii74–ii77. doi:10.1136/ard.2004.030783

    Article  CAS  PubMed  Google Scholar 

  5. Gartehner G, Hansen RA, Thieda P, Jonas B, Lohr KN, Carey T (2005) Drug class review on target immune modulators. Available via DIALOG. http://www.ohsu.edu/drugeffectiveness. Accessed 1 Dec 2008

  6. Baker H, Ryan TJ (1968) Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol 80:771–793. doi:10.1111/j.1365-2133.1968.tb11947.x

    Article  CAS  PubMed  Google Scholar 

  7. Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56:1051–1066. doi:10.1002/art.22489

    Article  CAS  PubMed  Google Scholar 

  8. Kuek A, Hazleman BL, Ostör AJ (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83(978):251–260. doi:10.1136/pgmj.2006.052688

    Article  CAS  PubMed  Google Scholar 

  9. Nakayama Y, Shimizu Y, Hirano K, Ebata K, Minemura M, Watanabe A, Sugiyama T (2005) CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis. Hepatology 42(4):915–924. doi:10.1002/hep.20872

    Article  CAS  PubMed  Google Scholar 

  10. Westhovens R, Verschueren P (2008) Translating co-stimulation blockade into clinical practice. Arthritis Res Ther 10(Suppl 1):S4. doi:10.1186/ar2415

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Roseli Monteiro Callado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vieira, F.J.F., Callado, M.R.M. & Vieira, W.P. Abatacept as an option therapy in difficult to treat psoriatic arthritis. Rheumatol Int 30, 849–850 (2010). https://doi.org/10.1007/s00296-009-1041-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1041-1

Keywords

Navigation